直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

PTAB May Flex its Discretionary Muscle to Deny Duplicative IPR Petitions

October 20, 2014

Authored and Edited by James D. Stein

The AIA granted the Board broad discretion to determine how a matter will (or will not) proceed if another matter involving the same patent has been brought before the USPTO, especially where “the same or substantially the same prior art or arguments were previously presented to the Office.” See 35 U.S.C. § 325(d).

The Board recently exercised this discretion in an “informative” decision denying an IPR petition in Medtronic, Inc. v. NuVasive, Inc., IPR2014-00487, Paper 8 (Sept. 11, 2014). The petitioner had previously filed two IPR petitions challenging the same patent. The Board denied one petition and instituted the other. The petition here admitted that it was “essentially a duplicate” of the denied petition, but contended that it corrected deficiencies, provided new evidence and arguments, and presented grounds that were not redundant to the grounds presented in the instituted petition. The Board rejected petitioner’s arguments based on three key points:

  1. The new petition failed to “provide any specific reasoning” to support the argument that its grounds were not redundant to the grounds in the instituted petition other than stating that “those grounds are based on different prior art references and different arguments”;
  2.  The instituted proceeding involved the same patent and claims, with oral argument already scheduled for November; and
  3. The grounds proposed in the new petition were “nearly identical” to the grounds proposed in the denied petition.

The decision provides practitioners a few key takeaways. First, petitioners wanting to file a second petition challenging the same patent should attempt to file it with the first petition, or shortly thereafter, so the Board can institute the proceedings together and place them on the same schedule, eliminating any concerns of inefficiency. Second, the Board has the discretion to cite inter-petition redundancy to deny a second petition, so petitioners would be well-served to specifically explain how the grounds in a follow-on petition differ from the grounds in previous petitions—even when filed by different parties. Finally, petitioners should take care that their original petitions are not marred by any institution-threatening flaws (e.g., lacking discussion of a motivation for combining two references in a obviousness ground), as the Board may apply § 325(d) to deny a later petition attempting to correct those flaws because it presents identical or nearly identical grounds.

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Conference

Best Practices and Tech in Intellectual Property Conference 2026

May 17, 2026

Tel Aviv

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

INCONTESTABLE® Blog

Netflix Prevails in Copyright Infringement Suit Regarding Tiger King

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP